# Joint care can start small and change when needed

*Treatment Choices | Stem Cells Queen Creek*

> Stem cells Queen Creek guide to daily relief, medicine, regenerative options and surgery.

Which care makes sense for a joint that stays sore? Start with the activity you miss. Then compare relief, cost, time away from home, recovery, and risks. Easy movement, pacing, and a cane or brace often come first. Medicine may help you stay active. A joint procedure may come up when those choices haven't helped enough. Surgery may fit a badly worn joint that limits daily life. I'd ask what improvement is reasonable, when you'll notice it, and what the clinician will advise if the first choice hasn't helped enough.

## Home care and medicine can make movement easier

A regular exercise routine can strengthen the muscles near your joint. Pacing can keep one hard day from spoiling the next several days. Walking may feel easier with a fitted cane or brace. Your clinician can adjust the exercises and support as your soreness changes. These choices take time, so ask when to review your progress.

Medicine isn't the whole answer.

Creams or pills can reduce the ache for some people. They can also carry risks for your stomach, kidneys, heart, or other medicine. Check with your regular clinician before using them. Relief matters most when it helps you move and sleep.

## Non-surgical procedures may come up when soreness remains

Biologic therapies are joint procedures using a product prepared from blood, marrow, or fat. PRP means platelet-rich plasma, a product made from your blood. The clinic spins the blood so platelets—the tiny blood pieces that gather when you bleed—collect into a smaller amount of liquid. The finished liquid holds more platelets. A clinician then puts the prepared product inside the aching joint. For a marrow option, the clinician draws marrow from the pelvis, spins it, and delivers the prepared part to the joint. The goal is to reduce the ache and make movement easier, though results can differ. Ask exactly what will be used and what care follows.

When the ache stays, QC Kinetix provides regenerative treatment options—non-surgical clinic procedures using prepared blood or marrow. Its medical providers are the clinicians who examine you, perform the procedure, and explain recovery. Ask whether the choice fits your joint, health, and missed activities. If it doesn't, ask whether more exercise, medicine, physical therapy, or surgery fits better.

## Surgery is worth discussing when daily life stays limited

Meeting a surgeon doesn't mean you'll need an operation. It gives you another reading of the exam and the available care. Ask what recovery would involve and whether waiting could make surgery harder. If you have soreness at rest, a visibly bent joint, or very little movement, another joint procedure may only delay a surgeon's advice.

Hearing the choices doesn't commit you that day.

Ask the same basic questions about every option. What is it meant to change? When might you know whether it helped? What does recovery require? Clear answers let you compare non-surgical care directly against an operation on your knee or hip.

## Sources

1. The OARSI non-surgical management guideline evaluated 60 interventions with GRADE methodology and built its recommendations around core treatments - structured exercise, weight management and self-management education - for every patient with knee osteoarthritis, regardless of what else is added.
   Bannuru RR, et al. — [OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis](https://pubmed.ncbi.nlm.nih.gov/31278997/). *Osteoarthritis Cartilage*, 2019. DOI: 10.1016/j.joca.2019.06.011.
2. The International Society for Cell & Gene Therapy position statement holds that the acronym MSC should mean mesenchymal STROMAL cells and should only be called stem cells where rigorous in vitro and in vivo evidence of stemness exists for that specific preparation.
   Viswanathan S, et al. — [Mesenchymal stem versus stromal cells: International Society for Cell & Gene Therapy (ISCT®) Mesenchymal Stromal Cell committee position statement on nomenclature](https://pubmed.ncbi.nlm.nih.gov/31526643/). *Cytotherapy*, 2019. DOI: 10.1016/j.jcyt.2019.08.002.
3. The 2018 AAOS/NIH consensus work group recommended that minimally manipulated mixed cell preparations be called CELL THERAPY rather than stem cell therapy, and that their untested and uncharacterised nature be clearly communicated to patients and the public, because stem cells have properties these preparations do not meet.
   Chu CR, et al. — [Optimizing Clinical Use of Biologics in Orthopaedic Surgery: Consensus Recommendations From the 2018 AAOS/NIH U-13 Conference](https://pubmed.ncbi.nlm.nih.gov/30300216/). *J Am Acad Orthop Surg*, 2019. DOI: 10.5435/JAAOS-D-18-00305.
4. 21 CFR 1271.10(a) sets the four criteria a human cell or tissue product must meet to be regulated SOLELY under section 361 of the Public Health Service Act: it must be minimally manipulated; intended for homologous use only, as reflected by labeling and advertising; not combined with another article beyond water, crystalloids or a preserving agent; and either have no systemic effect and not depend on the metabolic activity of living cells, or else be for autologous use, use in a close blood relative, or reproductive use.
   US Code of Federal Regulations, Title 21 — [21 CFR 1271.10 - Are my HCT/P's regulated solely under section 361 of the PHS Act](https://www.ecfr.gov/current/title-21/chapter-I/subchapter-L/part-1271/subpart-A/section-1271.10). *null*, 2004.
5. The AAOS Surgical Management of Osteoarthritis of the Knee clinical practice guideline sets out 16 recommendations and seven options for surgical management based on a systematic review of the published evidence - the reference point for when a joint has moved past the injectable tier.
   Srivastava AK, et al. — [American Academy of Orthopaedic Surgeons Clinical Practice Guideline Summary of Surgical Management of Osteoarthritis of the Knee](https://pubmed.ncbi.nlm.nih.gov/37883429/). *J Am Acad Orthop Surg*, 2023. DOI: 10.5435/JAAOS-D-23-00338.
6. A systematic review of 21 studies re-examining the familiar '20 percent are dissatisfied after knee replacement' figure found the actual average dissatisfaction rate was 10 percent, and 7.3 percent when complications were excluded - the surgical benchmark a cash-pay injection is implicitly competing against.
   DeFrance MJ, et al. — [Are 20% of Patients Actually Dissatisfied Following Total Knee Arthroplasty? A Systematic Review of the Literature](https://pubmed.ncbi.nlm.nih.gov/36252743/). *J Arthroplasty*, 2023. DOI: 10.1016/j.arth.2022.10.011.
7. A 2024 systematic review of bone marrow aspirate concentrate for HIP osteoarthritis found the clinical evidence base thinner than for the knee, with most studies uncontrolled - the joint matters, and evidence does not transfer across joints.
   Chandrashekar S, et al. — [Safety and Efficacy of Bone-Marrow Aspirate Concentrate in Hip Osteoarthritis: A Systematic Review of Current Clinical Evidence](https://pubmed.ncbi.nlm.nih.gov/38948376/). *Indian J Orthop*, 2024. DOI: 10.1007/s43465-024-01183-7.
8. A phase I single-arm study of 10 patients with chronic discogenic low back pain found a single intradiscal injection of adipose-derived MSCs with hyaluronic acid produced no procedure-related or cell-related adverse events over 12 months - a safety signal in 10 people, not an efficacy result.
   Kumar H, et al. — [Safety and tolerability of intradiscal implantation of combined autologous adipose-derived mesenchymal stem cells and hyaluronic acid in patients with chronic discogenic low back pain: 1-year follow-up of a phase I study](https://pubmed.ncbi.nlm.nih.gov/29141662/). *Stem Cell Res Ther*, 2017. DOI: 10.1186/s13287-017-0710-3.
9. A CDC Notes from the Field report in MMWR documented infections in US patients during 2018 after receipt of bacterially contaminated umbilical cord blood-derived products used for indications other than blood or immune reconstitution.
   Perkins KM, et al. — [Notes from the Field: Infections After Receipt of Bacterially Contaminated Umbilical Cord Blood-Derived Stem Cell Products for Other Than Hematopoietic or Immunologic Reconstitution - United States, 2018](https://pubmed.ncbi.nlm.nih.gov/30571672/). *MMWR Morb Mortal Wkly Rep*, 2018. DOI: 10.15585/mmwr.mm6750a5.
10. A randomized trial comparing commercially available systems in 71 patients found microfragmented adipose tissue equivalent to leukocyte-rich PRP on KOOS pain at 12 months.
   Baria M, et al. — [Microfragmented Adipose Tissue Is Equivalent to Platelet-Rich Plasma for Knee Osteoarthritis at 12 Months Posttreatment: A Randomized Controlled Trial](https://pubmed.ncbi.nlm.nih.gov/38510323/). *Orthop J Sports Med*, 2024. DOI: 10.1177/23259671241233916.
11. In a 480-patient, four-arm, multicenter randomized phase 2/3 trial, none of three orthobiologic cell injections - autologous bone marrow aspirate concentrate, autologous adipose stromal vascular fraction, or allogeneic umbilical cord tissue-derived mesenchymal stromal cells - was superior to any other, or to a corticosteroid injection control, on pain at 12 months.
   Mautner K, et al. — [Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial](https://pubmed.ncbi.nlm.nih.gov/37919438/). *Nat Med*, 2023. DOI: 10.1038/s41591-023-02632-w.
12. A Bayesian network meta-analysis of 48 randomized trials covering 9,338 knees found hyaluronic acid and PRP significantly improved pain versus placebo, and that BMAC accounted for only 2.5 percent of the studied injections - the thinnest evidence base of the four comparators.
   Jawanda H, et al. — [Platelet-Rich Plasma, Bone Marrow Aspirate Concentrate, and Hyaluronic Acid Injections Outperform Corticosteroids in Pain and Function Scores at a Minimum of 6 Months as Intra-Articular Injections for Knee Osteoarthritis: A Systematic Review and Network Meta-analysis](https://pubmed.ncbi.nlm.nih.gov/38331363/). *Arthroscopy*, 2024. DOI: 10.1016/j.arthro.2024.01.037.
13. A controlled randomized phase I/II trial in 26 patients found repeated dosing of culture-expanded umbilical cord-derived MSCs at baseline and 6 months produced lower WOMAC pain at 12 months (1.1 +/- 1.3) than hyaluronic acid (4.3 +/- 3.5), while a single MSC dose did not separate from hyaluronic acid.
   Matas J, et al. — [Umbilical Cord-Derived Mesenchymal Stromal Cells (MSCs) for Knee Osteoarthritis: Repeated MSC Dosing Is Superior to a Single MSC Dose and to Hyaluronic Acid in a Controlled Randomized Phase I/II Trial](https://pubmed.ncbi.nlm.nih.gov/30592390/). *Stem Cells Transl Med*, 2019. DOI: 10.1002/sctm.18-0053.
14. On 27 September 2024 the Ninth Circuit held in United States v. California Stem Cell Treatment Center that stromal vascular fraction produced by enzymatically digesting a patient's own fat IS a drug under the Federal Food, Drug, and Cosmetic Act, and that the same surgical procedure exception does not apply because the removed fat and the implanted SVF are not the same thing. The district court's ruling for the clinics was reversed.
   United States Court of Appeals for the Ninth Circuit — [United States v. California Stem Cell Treatment Center, Inc., No. 22-56014 (9th Cir. Sept. 27, 2024)](https://cdn.ca9.uscourts.gov/datastore/opinions/2024/09/27/22-56014.pdf). *null*, 2024.

## Soreness that has not settled deserves a closer look

QC Kinetix provides regenerative treatment options—non-surgical procedures using material prepared from your blood or bone marrow. At its Chandler office, a clinician examines your joint and puts the prepared material into the sore area during the procedure. Bring records and notes about what raises or eases the soreness. Call (602) 837-PAIN.

Schedule a free consultation: <https://comprehensive-pain-management.qckaz.com/?src=stemcellsqueencreek.com>

---

What may ease the soreness, and when an exam makes sense.

Why a joint stays sore, ways to help it at home, reasons for an exam, and what local non-surgical treatment involves.

Answers about aching joints, simple relief, reasons for prompt care, and local visits.

This site is operated by the owners of the QC Kinetix Phoenix-area clinics, including the Chandler office recommended here; the business benefits when readers book, so examine the sources and compare the options.

© 2026 Queen Creek Joint Fieldguide. General health education only, not medical advice or a diagnosis for an individual joint.